Curis Inc Total Assets
Curis Inc total assets. Based on the latest financial reports, Curis Inc (CRIS) holds total assets worth $29.69 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see CRIS company net worth for the company's overall valuation and market capitalisation.
Total Assets of Curis Inc (1999–2025)
Total assets of Curis Inc from 1999 to 2025. This chart illustrates how Curis Inc's total assets have evolved over time, based on quarterly financial data. See CRIS share price today for real-time trading data and today's change.
Curis Inc - Asset Composition Analysis
Curis Inc Total Assets Breakdown (December 2025)
Curis Inc total assets breakdown as of December 2025. Curis Inc's total assets of $29.69 Million consist of 34.6% current assets and 65.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 25.4% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $8.98 Million | 45.0% |
Asset Composition Trend (1999–2025)
This chart illustrates how Curis Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Curis Inc (CRIS) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Curis Inc's current assets represent 34.6% of total assets in 2025, a decrease from 74.7% in 1999.
- Cash Position: Cash and equivalents constituted 25.4% of total assets in 2025, up from 9.5% in 1999.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 44.0% of total assets, an increase from 0.0% in 1999.
- Asset Diversification: The largest asset category is goodwill at 45.0% of total assets.
Curis Inc Competitors by Total Assets
Key competitors of Curis Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hyloris Developmentsen Sa
BR:HYL
|
Belgium | €37.05 Million |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $11.72 Billion |
|
Oruka Therapeutics, Inc.
NASDAQ:ORKA
|
USA | $1.14 Billion |
|
Gempharmatech Co. Ltd. A
SHG:688046
|
China | CN¥2.80 Billion |
|
Vor Biopharma Inc
NASDAQ:VOR
|
USA | $481.05 Million |
|
Inventiva S.A
PA:IVA
|
France | €249.51 Million |
|
Sunmax Biotechnology Co Ltd
TWO:4728
|
Taiwan | NT$1.90 Billion |
|
Apnimed, Inc. Common Stock
NASDAQ:APMD
|
USA | $342.63 Million |
Curis Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.00 | 1.23 | 19.90 |
| Quick Ratio | 1.00 | 1.23 | 19.90 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $27.00K | $4.69 Million | $148.67 Million |
Curis Inc - Advanced Valuation Insights
This section examines the relationship between Curis Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.56 |
| Latest Market Cap to Assets Ratio | 0.09 |
| Asset Growth Rate (YoY) | -51.6% |
| Total Assets | $19.97 Million |
| Market Capitalization | $1.73 Million USD |
Valuation Analysis
Below Book Valuation: The market values Curis Inc's assets below their book value (0.09x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Curis Inc's assets decreased by 51.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Curis Inc (1999–2025)
The table below shows the annual total assets of Curis Inc from 1999 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $19.97 Million | -51.62% |
| 2024-12-31 | $41.27 Million | -46.60% |
| 2023-12-31 | $77.28 Million | -29.00% |
| 2022-12-31 | $108.85 Million | -32.93% |
| 2021-12-31 | $162.30 Million | -20.58% |
| 2020-12-31 | $204.36 Million | +482.10% |
| 2019-12-31 | $35.11 Million | -6.04% |
| 2018-12-31 | $37.37 Million | -49.37% |
| 2017-12-31 | $73.80 Million | +27.78% |
| 2016-12-31 | $57.75 Million | -39.19% |
| 2015-12-31 | $94.97 Million | +51.67% |
| 2014-12-31 | $62.61 Million | -22.31% |
| 2013-12-31 | $80.59 Million | +15.16% |
| 2012-12-31 | $69.98 Million | +45.25% |
| 2011-12-31 | $48.18 Million | -4.87% |
| 2010-12-31 | $50.65 Million | +40.31% |
| 2009-12-31 | $36.10 Million | -9.71% |
| 2008-12-31 | $39.98 Million | -25.71% |
| 2007-12-31 | $53.82 Million | +2.96% |
| 2006-12-31 | $52.27 Million | -14.19% |
| 2005-12-31 | $60.91 Million | -9.94% |
| 2004-12-31 | $67.63 Million | +21.35% |
| 2003-12-31 | $55.74 Million | -10.74% |
| 2002-12-31 | $62.44 Million | -56.86% |
| 2001-12-31 | $144.76 Million | -20.76% |
| 2000-12-31 | $182.68 Million | +532.29% |
| 1999-12-31 | $28.89 Million | -- |
About Curis Inc
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial in patients with relapsed/refractory primary central nervous system lymphoma. … Read more